Blood-Brain Barrier and Gut Barrier Dysfunction in Chronic Kidney Disease with a Focus on Circulating Biomarkers and Tight Junction Proteins

Researchers examined blood–brain barrier disruption, by assessing brain-derived neurotropic factor, neuron-specific enolase levels, and gut-blood barrier disruption by trimethylamine N-oxide in chronic kidney disease patients.